Cerebral Stock
Mental Health Telemedicine
Sign up today and learn more about Cerebral Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Cerebral Stock
Cerebral is a mental health telemedicine company. Cerebral offers therapy and medication for patients with mental illnesses such as anxiety or depression. Cerebral claims to offer its platform to individuals, employers, and payers.
Cerebral was founded in 2020 and is headquartered in San Francisco, California. Notable investors include SoftBank Vision Fund, WestCap, and Access Industries.
Investors
WestCap
Liquid 2 Ventures
Whatnot, Cerebral, Newfront Insurance, Swiftly, Mux, Parsley Health, Curebase
Funding History
| September 2020 | $637K |
|---|---|
| September 2020 | $3K |
| September 2020 | $875K |
| September 2020 | $659K |
| September 2020 | $404K |
| September 2020 | $5K |
| September 2020 | $5.1M |
| September 2020 | $27.6M |
| March 2021 | $126M |
| November 2021 | $300M |
Management
Chief Executive Officer
Kyle Robertson
Chief Financial Officer
Meg Miller McKenna
Press
theverge - Dec, 30 2023
Mental health app Cerebral got in trouble again.techtimes - Sep, 20 2023
Meet Cerebral, the Startup Stepping Up To Democratize High-Quality Mental Health Carehealthcareitnews - Mar, 13 2023
Cerebral says 3M affected by a patient data breachow - Mar, 12 2023
Cerebral Admits That it Wrongly Shared Data of 3.1M UsersTechCrunch - Mar, 11 2023
Telehealth startup Cerebral shared millions of patients’ data with advertisersEquityZen Recognized As:
